3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Stomatitis
1
Squamous Cell Carcinoma of Head and Neck
1
Prostatic Neoplasms
1
Carcinoma, Squamous Cell
1
Interventions
pembrolizumab
8
Cetuximab
8
Cisplatin
6
Fluorouracil
5
Paclitaxel
4
durvalumab
3
Radiotherapy
3
Leucovorin
3
Docetaxel
3
Carboplatin
3
tremelimumab
2
niraparib
2
avelumab
2
Radiotherapy, Intensity-Modulated
2
Pemetrexed
2
Nivolumab
2
Ipilimumab
2
Bevacizumab
2
zalutumumab
1
yeast-CEA vaccine
1
spartalizumab
1
smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic
1
regorafenib
1
penpulimab
1
paclitaxel poliglumex
1
osimertinib
1
necitumumab
1
dostarlimab
1
demplatin pegraglumer
1
cobimetinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Carcinoma, Squamous Cell
×
Tea
×
Clear all
NCT06875791
2025-04-01
TEMOR
Fundacion Clinica Valle del Lili
Phase 1/2
Not yet recruiting
40 enrolled